Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs)

SHM Pour; CE de Keyser; PC Souverein; FW Asselbergs; A Hofman; BH Stricker; A de Boer; A-H Maitland-van der Zee

Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs)

SHM Pour, CE de Keyser, PC Souverein, FW Asselbergs, A Hofman, BH Stricker, A de Boer, A-H Maitland-van der Zee

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Academic › peer-review

Original language	English
Title of host publication	PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Publisher	Wiley-Blackwell
Pages	379-379
Number of pages	1
Volume	23
Publication status	Published - 1 Oct 2014

Access to Document

https://www.webofscience.com/api/gateway?GWVersion=2SrcApp=PARTNER_APPSrcAuth=LinksAMRKeyUT=WOS:000342763600702DestLinkType=FullRecordDestApp=ALL_WOSUsrCustomerID=f41074198c063036414efcbc916f8956

Cite this

Pour, SHM., de Keyser, CE., Souverein, PC., Asselbergs, FW., Hofman, A., Stricker, BH., de Boer, A., & Maitland-van der Zee, A.-H. (2014). Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs). In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 23, pp. 379-379). Wiley-Blackwell. https://www.webofscience.com/api/gateway?GWVersion=2SrcApp=PARTNER_APPSrcAuth=LinksAMRKeyUT=WOS:000342763600702DestLinkType=FullRecordDestApp=ALL_WOSUsrCustomerID=f41074198c063036414efcbc916f8956

@inproceedings{1268f5e0d6d74d8e99cf56bbdbf70458,

title = "Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs)",

author = "SHM Pour and {de Keyser}, CE and PC Souverein and FW Asselbergs and A Hofman and BH Stricker and {de Boer}, A and {Maitland-van der Zee}, A-H",

year = "2014",

month = oct,

day = "1",

language = "English",

volume = "23",

pages = "379--379",

booktitle = "PHARMACOEPIDEMIOLOGY AND DRUG SAFETY",

publisher = "Wiley-Blackwell",

}

Pour, SHM, de Keyser, CE, Souverein, PC, Asselbergs, FW, Hofman, A, Stricker, BH, de Boer, A & Maitland-van der Zee, A-H 2014, Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs). in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. vol. 23, Wiley-Blackwell, pp. 379-379. <https://www.webofscience.com/api/gateway?GWVersion=2SrcApp=PARTNER_APPSrcAuth=LinksAMRKeyUT=WOS:000342763600702DestLinkType=FullRecordDestApp=ALL_WOSUsrCustomerID=f41074198c063036414efcbc916f8956>

Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs). / Pour, SHM; de Keyser, CE; Souverein, PC et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. Vol. 23 Wiley-Blackwell, 2014. p. 379-379.

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Academic › peer-review

TY - GEN

T1 - Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs)

AU - Pour, SHM

AU - de Keyser, CE

AU - Souverein, PC

AU - Asselbergs, FW

AU - Hofman, A

AU - Stricker, BH

AU - de Boer, A

AU - Maitland-van der Zee, A-H

PY - 2014/10/1

Y1 - 2014/10/1

M3 - Conference contribution

VL - 23

SP - 379

EP - 379

BT - PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

PB - Wiley-Blackwell

ER -